• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过全身给药的血管归巢肽在氧诱导视网膜病变(OIR)中对视网膜的选择性靶向和组织渗透

Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR).

作者信息

Vähätupa Maria, Salonen Niklas, Uusitalo-Järvinen Hannele, Järvinen Tero A H

机构信息

Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.

Eye Centre & Department of Orthopedics & Traumatology, Tampere University Hospital, 33520 Tampere, Finland.

出版信息

Pharmaceutics. 2021 Nov 15;13(11):1932. doi: 10.3390/pharmaceutics13111932.

DOI:10.3390/pharmaceutics13111932
PMID:34834347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8618640/
Abstract

Pathological angiogenesis is the hallmark of ischemic retinal diseases among them retinopathy of prematurity (ROP) and proliferative diabetic retinopathy (PDR). Oxygen-induced retinopathy (OIR) is a pure hypoxia-driven angiogenesis model and a widely used model for ischemic retinopathies. We explored whether the vascular homing peptide CAR (CARSKNKDC) which recognizes angiogenic blood vessels can be used to target the retina in OIR. We were able to demonstrate that the systemically administered CAR vascular homing peptide homed selectively to the preretinal neovessels in OIR. As a cell and tissue-penetrating peptide, CAR also penetrated into the retina. Hyperoxia used to induce OIR in the retina also causes bronchopulmonary dysplasia in the lungs. We showed that the CAR peptide is not targeted to the lungs in normal mice but is targeted to the lungs after hyperoxia-/hypoxia-treatment of the animals. The site-specific delivery of the CAR peptide to the pathologic retinal vasculature and the penetration of the retinal tissue may offer new opportunities for treating retinopathies more selectively and with less side effects.

摘要

病理性血管生成是缺血性视网膜疾病的标志,其中包括早产儿视网膜病变(ROP)和增殖性糖尿病视网膜病变(PDR)。氧诱导性视网膜病变(OIR)是一种纯粹由缺氧驱动的血管生成模型,也是缺血性视网膜病变广泛使用的模型。我们探究了识别血管生成血管的血管归巢肽CAR(CARSKNKDC)是否可用于在OIR中靶向视网膜。我们能够证明,全身给药的CAR血管归巢肽选择性归巢至OIR中的视网膜前新生血管。作为一种细胞和组织穿透肽,CAR也可穿透进入视网膜。用于在视网膜中诱导OIR的高氧也会导致肺部支气管肺发育不良。我们表明,CAR肽在正常小鼠中不会靶向肺部,但在对动物进行高氧/低氧处理后会靶向肺部。CAR肽向病理性视网膜血管系统的位点特异性递送以及视网膜组织的穿透可能为更具选择性且副作用更少地治疗视网膜病变提供新机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/4e75e3c87368/pharmaceutics-13-01932-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/d45fa25f171b/pharmaceutics-13-01932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/e9020c0d1c35/pharmaceutics-13-01932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/6d57ff8acfd3/pharmaceutics-13-01932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/1e0841de8409/pharmaceutics-13-01932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/4e75e3c87368/pharmaceutics-13-01932-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/d45fa25f171b/pharmaceutics-13-01932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/e9020c0d1c35/pharmaceutics-13-01932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/6d57ff8acfd3/pharmaceutics-13-01932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/1e0841de8409/pharmaceutics-13-01932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3518/8618640/4e75e3c87368/pharmaceutics-13-01932-g005.jpg

相似文献

1
Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR).通过全身给药的血管归巢肽在氧诱导视网膜病变(OIR)中对视网膜的选择性靶向和组织渗透
Pharmaceutics. 2021 Nov 15;13(11):1932. doi: 10.3390/pharmaceutics13111932.
2
Proteomics Analysis of R-Ras Deficiency in Oxygen Induced Retinopathy.氧诱导视网膜病变中 R-Ras 缺失的蛋白质组学分析。
Int J Mol Sci. 2023 Apr 26;24(9):7914. doi: 10.3390/ijms24097914.
3
Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies.探索氧诱导视网膜病变模型以发现视网膜病变新的治疗药物靶点。
Front Pharmacol. 2020 Jun 11;11:873. doi: 10.3389/fphar.2020.00873. eCollection 2020.
4
SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets.SWATH-MS 蛋白质组学分析氧诱导性视网膜病变揭示新的潜在治疗靶点。
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3294-3306. doi: 10.1167/iovs.18-23831.
5
MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.miR-203a-3p 通过靶向 VEGFA 和 HIF-1α 抑制视网膜血管生成并减轻氧诱导的视网膜病变 (OIR) 大鼠模型中的增生性糖尿病性视网膜病变。
Clin Exp Pharmacol Physiol. 2020 Jan;47(1):85-94. doi: 10.1111/1440-1681.13163. Epub 2019 Oct 7.
6
Oxygen-induced retinopathy: a model for vascular pathology in the retina.氧诱导视网膜病变:视网膜血管病变模型。
Eye (Lond). 2010 Mar;24(3):416-21. doi: 10.1038/eye.2009.306. Epub 2009 Dec 11.
7
Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.由于预防了高氧诱导的血管闭塞,缺乏脯氨酰羟化酶-1 可减少缺血性视网膜病变中的视网膜新生血管、血管通透性和细胞凋亡。
Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7565-73. doi: 10.1167/iovs.11-8002.
8
Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.抑制肿瘤坏死因子-α可改善生理性血管生成并减少缺血性视网膜病变中的病理性新生血管形成。
Am J Pathol. 2005 Feb;166(2):637-44. doi: 10.1016/s0002-9440(10)62284-5.
9
The 50/10 Oxygen-Induced Retinopathy Model Serves as a Hyperoxia and Hypoxia Model of Bronchopulmonary Dysplasia.50/10 氧诱导视网膜病变模型可作为支气管肺发育不良的高氧和低氧模型。
Am J Med Sci. 2018 Jun;355(6):581-587. doi: 10.1016/j.amjms.2018.01.015. Epub 2018 Feb 2.
10
[Pathological role of apelin in angiogenic eye disease].[阿片肽在眼部血管生成性疾病中的病理作用]
Yakugaku Zasshi. 2011;131(8):1201-6. doi: 10.1248/yakushi.131.1201.

引用本文的文献

1
Screening of homing and tissue-penetrating peptides by microdialysis and in vivo phage display.通过微透析和体内噬菌体展示筛选归巢和组织穿透肽。
Life Sci Alliance. 2025 Feb 11;8(5). doi: 10.26508/lsa.202201490. Print 2025 May.
2
Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function.系统给予的创伤归巢肽通过调节硫酸乙酰肝素蛋白聚糖-4 的功能来加速伤口愈合。
Nat Commun. 2023 Dec 6;14(1):8069. doi: 10.1038/s41467-023-43848-1.
3
Proteomics Analysis of R-Ras Deficiency in Oxygen Induced Retinopathy.

本文引用的文献

1
IL-13Rα1 Suppresses Tumor Progression in Two-Stage Skin Carcinogenesis Model by Regulating Regulatory T Cells.IL-13Rα1 通过调节调节性 T 细胞抑制两阶段皮肤癌变模型中的肿瘤进展。
J Invest Dermatol. 2022 Jun;142(6):1565-1575.e17. doi: 10.1016/j.jid.2021.11.013. Epub 2021 Nov 19.
2
Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology.全身给药的归巢肽靶向营养不良性病变并递送转化生长因子-β(TGFβ)抑制剂以减轻小鼠肌肉营养不良病理。
Pharmaceutics. 2021 Sep 18;13(9):1506. doi: 10.3390/pharmaceutics13091506.
3
氧诱导视网膜病变中 R-Ras 缺失的蛋白质组学分析。
Int J Mol Sci. 2023 Apr 26;24(9):7914. doi: 10.3390/ijms24097914.
4
Editorial on Special Issue "Precision Delivery of Drugs and Imaging Agents with Peptides".关于“肽介导的药物和成像剂精准递送”特刊的社论
Pharmaceutics. 2022 Feb 23;14(3):486. doi: 10.3390/pharmaceutics14030486.
Molecular Features of Classic Retinal Drugs, Retinal Therapeutic Targets and Emerging Treatments.
经典视网膜药物的分子特征、视网膜治疗靶点及新兴治疗方法
Pharmaceutics. 2021 Jul 20;13(7):1102. doi: 10.3390/pharmaceutics13071102.
4
The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change.Ras 蛋白家族在正常和病理迁移及形态变化中的作用。
Am J Pathol. 2021 Sep;191(9):1499-1510. doi: 10.1016/j.ajpath.2021.05.008. Epub 2021 Jun 7.
5
R-Ras Deficiency in Pericytes Causes Frequent Microphthalmia and Perturbs Retinal Vascular Development.周细胞中 R-Ras 的缺失导致小眼症频繁发生,并扰乱视网膜血管发育。
J Vasc Res. 2021;58(4):252-266. doi: 10.1159/000514555. Epub 2021 Apr 19.
6
Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment-A Systematic Review.用于眼部后段局部给药的渗透促进剂——一项系统评价
Pharmaceutics. 2021 Feb 18;13(2):276. doi: 10.3390/pharmaceutics13020276.
7
Macropinocytosis as a cell entry route for peptide-functionalized and bystander nanoparticles.巨胞饮作用作为肽功能化纳米颗粒和旁观者纳米颗粒的细胞进入途径。
J Control Release. 2021 Jan 10;329:1222-1230. doi: 10.1016/j.jconrel.2020.10.049. Epub 2020 Oct 24.
8
Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.病理性血管生成需要 syndecan-4 来促进 VEGFA 诱导的 VE-钙黏蛋白内化。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1374-1389. doi: 10.1161/ATVBAHA.121.315941. Epub 2021 Feb 18.
9
Relapse of pathological angiogenesis: functional role of the basement membrane and potential treatment strategies.病理性血管再生的复发:基底膜的功能作用和潜在的治疗策略。
Exp Mol Med. 2021 Feb;53(2):189-201. doi: 10.1038/s12276-021-00566-2. Epub 2021 Feb 15.
10
Syndecan receptors: pericellular regulators in development and inflammatory disease.黏附素受体:发育和炎症性疾病中的细胞周调控因子。
Open Biol. 2021 Feb;11(2):200377. doi: 10.1098/rsob.200377. Epub 2021 Feb 10.